Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.
about
A Proteomic Approach to Analyze the Aspirin-mediated Lysine AcetylomeCyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.Aspirin inhibits glucose‑6‑phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites.Aspirin increases mitochondrial fatty acid oxidation.Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
P2860
Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aspirin acetylates wild type a ...... ated sites on recombinant p53.
@en
type
label
Aspirin acetylates wild type a ...... ated sites on recombinant p53.
@en
prefLabel
Aspirin acetylates wild type a ...... ated sites on recombinant p53.
@en
P2093
P2860
P1433
P1476
Aspirin acetylates wild type a ...... ated sites on recombinant p53.
@en
P2093
D Ramesh Kumar
G Jayarama Bhat
Guoqiang Ai
Lloyd F Alfonso
Rakesh Dachineni
Srinivasan Marimuthu
P2860
P2888
P304
P356
10.1007/S13277-015-4438-3
P577
2015-11-23T00:00:00Z
P5875
P6179
1009031981